Corin Group earns FDA clearance for robotic knee platform

Corin Group earned FDA 510(k) clearance for its Apollo robotic platform and software for total knee replacements, according to a Nov. 1 news release.

Advertisement

The system used Corin Group’s proprietary BalanceBot technology, which helps achieve personalize dynamic balance for patients. 

Corin Group is based in the United Kingdom. 

Advertisement

Next Up in Robotics

Advertisement

Comments are closed.